EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Repurposing Antifungal Drugs for Oral Cancer Treatment: Mechanistic Insights and Clinical Potential—A Narrative Review

Anju Mayadevi Nair, Bounika Esvanth Rao, Satish Srinivas Kondaveeti, Abhi Venkatshree Anand Kumar, Ruwan D Jayasinghe, Vijayalakshmi Ramshankar, Divyambika Catakapatri Venugopal

Journal of International Society of Preventive and Community Dentistry · 2026-05 · 16 (3) · 238-248

DOI: 10.4103/jispcd.jispcd_187_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of International Society of Preventive and Community Dentistry, online erschienen am 02.04.2026. Verfasst von Anju Mayadevi Nair und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine and Radiology, Sri Ramachandra Dental College and Hospital, Sri Ramachandra Institute of Higher Education and Research (D…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A bstract Objective: Oral squamous cell carcinoma (OSCC) continues to pose significant therapeutic challenges due to high recurrence rates and treatment-related toxicity. Drug repurposing offers an accelerated, cost-effective pathway to discover novel therapeutic indications for established medications. This narrative review evaluates the mechanistic rationale and clinical potential of repurposing antifungal agents, such as azoles and allylamines, as adjuvant therapies for OSCC.

Methods

A comprehensive literature search was performed across PubMed and Scopus (up to November 14, 2025). Studies were selected based on their focus on antifungal-mediated inhibition of OSCC growth and metastasis. Methodological quality was assessed using the Scale for the Evaluation of Narrative Review Articles.

Results

Antifungal agents, particularly itraconazole and terbinafine, exhibit potent antitumor activity by targeting key oncogenic pathways, including the Sonic Hedgehog (SHH) and phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling axes. Preclinical evidence indicates that these agents induce apoptosis, inhibit angiogenesis, and sensitize OSCC cells to standard chemotherapy and radiotherapy. Specifically, itraconazole shows promise in treating SHH-high tumors, while terbinafine reduces tumor proliferation through antiangiogenic mechanisms.

Conclusion

Antifungal drugs represent a biologically viable and resource-efficient strategy for enhancing OSCC treatment outcomes. To maximize clinical translation, future research must prioritize the development of nanoformulations and liposomal azoles to overcome existing bioavailability limitations.

Schlagwörter

Stichwörter der Autor:innen

AntifungalsPI3K/AKT/mTORdrug repurposinghedgehog signalingitraconazoleoral cancer

Autor:innen und Institutionen

  • Department of Oral Medicine and Radiology, Sri Ramachandra Dental College and Hospital, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, Tamil Nadu, India.
  • Department of Radiation Oncology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, Tamil Nadu, India.
  • Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya, Peradeniya, Sri Lanka.
  • Department of Cancer Biology and Molecular Diagnostics, Cancer Institute (WIA), Chennai, Tamil Nadu, India.

Zitieren

APA

Mayadevi Nair, A., Esvanth Rao, B., Kondaveeti, S. S., Anand Kumar, A. V., Jayasinghe, R. D., Ramshankar, V., & Catakapatri Venugopal, D. (2026). Repurposing Antifungal Drugs for Oral Cancer Treatment: Mechanistic Insights and Clinical Potential—A Narrative Review. Journal of International Society of Preventive and Community Dentistry, 16(3), 238-248. https://doi.org/10.4103/jispcd.jispcd_187_25

Vancouver

Mayadevi Nair A, Esvanth Rao B, Kondaveeti SS, Anand Kumar AV, Jayasinghe RD, Ramshankar V, et al. Repurposing Antifungal Drugs for Oral Cancer Treatment: Mechanistic Insights and Clinical Potential—A Narrative Review. Journal of International Society of Preventive and Community Dentistry. 2026;16(3):238-248. doi:10.4103/jispcd.jispcd_187_25

BibTeX
@article{MayadeviNair2026,
  author = {Mayadevi Nair, Anju and Esvanth Rao, Bounika and Kondaveeti, Satish Srinivas and Anand Kumar, Abhi Venkatshree and Jayasinghe, Ruwan D and Ramshankar, Vijayalakshmi and Catakapatri Venugopal, Divyambika},
  title = {Repurposing Antifungal Drugs for Oral Cancer Treatment: Mechanistic Insights and Clinical Potential—A Narrative Review},
  journal = {Journal of International Society of Preventive and Community Dentistry},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {238--248},
  doi = {10.4103/jispcd.jispcd_187_25}
}
Kostenlos starten →